NDC 41250-715

Meijer Maximum Redness Relief and Lubricant

Glycerin, Naphazoline Hci

Meijer Maximum Redness Relief and Lubricant is a Ophthalmic Solution/ Drops in the Human Otc Drug category. It is labeled and distributed by Meijer Distribution, Inc.. The primary component is Glycerin; Naphazoline Hydrochloride.

Product ID41250-715_a0972334-4c0d-c28f-e053-2995a90a1f2f
NDC41250-715
Product TypeHuman Otc Drug
Proprietary NameMeijer Maximum Redness Relief and Lubricant
Generic NameGlycerin, Naphazoline Hci
Dosage FormSolution/ Drops
Route of AdministrationOPHTHALMIC
Marketing Start Date2020-03-11
Marketing CategoryOTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
Application Numberpart349
Labeler NameMeijer Distribution, Inc.
Substance NameGLYCERIN; NAPHAZOLINE HYDROCHLORIDE
Active Ingredient Strength1 g/100mL; g/100mL
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 41250-715-01

1 BOTTLE, DROPPER in 1 BOX (41250-715-01) > 15 mL in 1 BOTTLE, DROPPER
Marketing Start Date2020-03-11
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 41250-715-01 [41250071501]

Meijer Maximum Redness Relief and Lubricant SOLUTION/ DROPS
Marketing CategoryOTC monograph final
Application Numberpart349
Product TypeHUMAN OTC DRUG
Marketing Start Date2020-03-11

Drug Details

Active Ingredients

IngredientStrength
GLYCERIN.5 g/100mL

OpenFDA Data

SPL SET ID:9feb1818-c79b-23bf-e053-2995a90a1084
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1235200
  • UPC Code
  • 0713733914963
  • NDC Crossover Matching brand name "Meijer Maximum Redness Relief and Lubricant" or generic name "Glycerin, Naphazoline Hci"

    NDCBrand NameGeneric Name
    41250-715Meijer Maximum Redness Relief and LubricantGlycerin, Naphazoline HCI
    72476-012CareOne Maximum Redness Relief Eye DropsGlycerin, Naphazoline HCI
    41250-846Meijer Redness ReliefGlycerin, Naphazoline HCI
    0363-4546Walgreens Eye Drops Maximum Redness Relief 15mLGlycerin, Naphazoline HCI
    0363-4548Walgreens Redness Relief Eye Drops 15mLGlycerin, Naphazoline HCI

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.